Urinary tract infection is a common high incidence disease worldwide, it has become the second largest infectious disease after respiratory tract infection. It’s high morbidity and mortality is a serious threat to human health and life safety.
Diagnosis gold standard of urine bacteria bacterial culture identification and drug susceptibility analysis experiment, but the culture cycle is longer, usually to 5-7 days, and low positive rate, limited application range (some pathogens to in vitro culture), because from the onset to the report time is too long, easy to miss the acute phase optimal treatment period.
Nucleic acid testing is increasingly used in the pathogen diagnosis of urinary tract infections. Compared with gold standard of bacterial culture identification and drug susceptibility analysis experiment which usually takes about 5~7 days, nucleic acid testing can save a lot of time. The target of nucleic acid testing is the genetic material of the pathogen. Through the selective amplification of the target sequence, very high detection sensitivity and specificity can be achieved.
Since nucleic acid detection does not require bacterial isolation and culture, pathogens can be detected quickly in the early stage of the disease.
B.Product presentation
Urinary Tract Infection (UTI) &DR Panel is used for in vitro qualitative detection of 19 common pathogens and 12 drug resistance genes in urine samples.